Laura Rovedatti

Author PubWeight™ 11.76‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Targeting gut T cell Ca2+ release-activated Ca2+ channels inhibits T cell cytokine production and T-box transcription factor T-bet in inflammatory bowel disease. J Immunol 2009 1.22
2 Functional modulation of Crohn's disease myofibroblasts by anti-tumor necrosis factor antibodies. Gastroenterology 2007 1.19
3 Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac disease. Gastroenterology 2007 1.14
4 New pathogenic paradigms in inflammatory bowel disease. Inflamm Bowel Dis 2011 0.89
5 Absence of a role for interleukin-13 in inflammatory bowel disease. Eur J Immunol 2014 0.86
6 Recent advances in understanding ulcerative colitis. Intern Emerg Med 2011 0.85
7 Increased expression of mucosal addressin cell adhesion molecule 1 in the duodenum of patients with active celiac disease is associated with depletion of integrin alpha4beta7-positive T cells in blood. Hum Pathol 2009 0.85
8 Fibroblast activation protein expression in Crohn's disease strictures. Inflamm Bowel Dis 2010 0.85
9 Peripheral regulatory T cells and serum transforming growth factor-β: relationship with clinical response to infliximab in Crohn's disease. Inflamm Bowel Dis 2010 0.82
10 Recent advances in understanding Crohn's disease. Intern Emerg Med 2011 0.79
11 Involvement of CD40-CD40 ligand in uncomplicated and refractory celiac disease. Am J Gastroenterol 2010 0.77
12 Effect of tumor necrosis factor-α blockade on mucosal addressin cell-adhesion molecule-1 in Crohn's disease. Inflamm Bowel Dis 2013 0.77
13 Stromelysin-1 and macrophage metalloelastase expression in the intestinal mucosa of Crohn's disease patients treated with infliximab. Eur J Gastroenterol Hepatol 2009 0.76